1. START-GAP2/DLC2 is localized in focal adhesions via its N-terminal region
- Author
-
Jun-ichi Seike, Minoru Kiyota, Hideo Nishitani, Hitoshi Yagisawa, Yui Iwamae, Takuya Iino, and Katsuhisa Kawai
- Subjects
RHOA ,PTK2 ,Biophysics ,CDC42 ,Biochemistry ,Focal adhesion ,Mice ,Tensins ,Animals ,Humans ,Tensin ,Molecular Biology ,Paxillin ,Focal Adhesions ,biology ,Chemistry ,Tumor Suppressor Proteins ,Microfilament Proteins ,Cell Biology ,Actin cytoskeleton ,Phosphoric Monoester Hydrolases ,Protein Structure, Tertiary ,Cell biology ,biology.protein ,DLC1 ,HeLa Cells - Abstract
START-GAP2, also termed as DLC2, is a START domain-containing RhoGAP and a negative regulator of RhoA and Cdc42. Although it was reported as a tumor suppresser gene product, the molecular basis for function of START-GAP2 remains to be clarified. Here, we demonstrate that START-GAP2 is localized in focal adhesions through a "FAT (focal adhesion targeting)" region in the N-terminal half. START-GAP2 competes with START-GAP1/DLC1, another START domain-containing RhoGAP, in focal adhesion targeting. Moreover, the C-terminus of tensin2, one of focal adhesion components and reported to bind START-GAP1, also directly interacts with START-GAP2. These results suggest that START-GAP2 and START-GAP1 share the same molecular mechanism in targeting to focal adhesions.
- Published
- 2009
- Full Text
- View/download PDF